COVID-19 mRNA vaccine (ancestral variant) (RVAC Medicines)

N/A

Report date: 2025/12/12 17:32:39

Base Information

Drug NameCOVID-19 mRNA vaccine (ancestral variant) (RVAC Medicines)
Drug Alias NameSARS-CoV-2 vaccine (ancestral variant) (RVAC Medicines)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySingapore
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRvac Medicines (us) Inc
China Registration ClassN/A

Develop Information

Active CompaniesRvac Medicines (us) Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A